Official source Data mirrored from Centers for Medicare & Medicaid Services Open Payments · General Payments · CMS publication 2026-06-30 View official record

Covered recipient · General Payments record

SHANKER N DIXIT

Allopathic & Osteopathic Physicians Psychiatry & Neurology Neurology

NPI
1477558674
CMS profile
157757
Location
LAS VEGAS, NV

A name match is not confirmation of identity. CMS publishes records for different people under similar names; the NPI, specialty, and location shown on this page are the CMS-published fields that distinguish them.

Saved items

Saved only in this browser. No account or alerts.

Filter and download payment records

General Payments · PY2024 · Entire year

$11,588.02

271 records · 0 disputed

Summary and payment records

  • CMS publication 2026-06-30
Read the payment records

“Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.”

— Centers for Medicare & Medicaid Services, Open Payments

A reported payment reflects a financial relationship a company disclosed. It does not indicate wrongdoing or a conflict of interest, and it says nothing about the quality of a provider's care.

These records are submitted to CMS and attested to by the reporting companies. CMS publishes them as reported; this site mirrors them without independent verification.

A payment attributed to a provider may have been made to a third party — a hospital, practice, or research institution — rather than paid to the provider personally.

How these totals are calculated
  • This total is the sum of the individual General Payments record amounts CMS published for the labeled program year(s); each record amount is used unmodified. The total itself is computed by this site. Nothing is estimated, weighted, or combined across categories.
  • General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
  • Methodology & Data — sourcing, labeling, and limitations.

Provider summaries generated . CMS updates this data on an annual cycle, and corrections or successful disputes made at CMS may not yet appear here. The official CMS record is authoritative for the current state. View the official CMS record ↗

By nature of payment

PY2024 · entire year · sorted by reported total

By paying entity

PY2024 · entire year · sorted by reported total

Page 2 of 6; records 51–100 of 271 matching records. This page contains 50 records (maximum 50), not the full filtered export. Use the CSV download for all matching records.

IndustryPayments · General Payments

SHANKER N DIXIT

NPI 1477558674 · CMS profile ID 157757

Allopathic & Osteopathic Physicians / Psychiatry & Neurology / Neurology

LAS VEGAS, NV

A name match is not confirmation of identity. CMS publishes records for different people under similar names; the NPI, specialty, and location shown on this page are the CMS-published fields that distinguish them.

A payment attributed to a provider may have been made to a third party — a hospital, practice, or research institution — rather than paid to the provider personally.

General Payments, PY2024; Recipient scope: Physicians and non-physician practitioners; Reporting company: All reporting companies; Nature of payment: All payment types

Data edition: cms-20260630-workflow-20261105-v2; CMS publication: 2026-06-30; records imported: 2026-11-05T09:06:52.159882+00:00

Page 2 of 6; records 51–100 of 271 matching records. This page contains 50 records (maximum 50), not the full filtered export.

Filtered page: https://industrypayments.org/provider/npi-1477558674?year=2024&recipient=provider&page=2#records-h

CMS source: https://openpaymentsdata.cms.gov/dataset/e6b17c6a-2534-4207-a4a1-6746a14911ff

Cite these filtered records

The citation includes this program year, filters, data edition, and page of results.

Plain
SHANKER N DIXIT, NPI 1477558674, CMS profile ID 157757. General Payments, PY2024; Recipient scope: Physicians and non-physician practitioners; Reporting company: All reporting companies; Nature of payment: All payment types. Data edition: cms-20260630-workflow-20261105-v2; CMS publication: 2026-06-30; records imported: 2026-11-05T09:06:52.159882+00:00. Page 2 of 6; records 51–100 of 271 matching records. This page contains 50 records (maximum 50), not the full filtered export. IndustryPayments. https://industrypayments.org/provider/npi-1477558674?year=2024&recipient=provider&page=2#records-h. Source: https://openpaymentsdata.cms.gov/dataset/e6b17c6a-2534-4207-a4a1-6746a14911ff.
APA 7
IndustryPayments. (2026). SHANKER N DIXIT, NPI 1477558674, CMS profile ID 157757. General Payments, PY2024; Recipient scope: Physicians and non-physician practitioners; Reporting company: All reporting companies; Nature of payment: All payment types. Data edition: cms-20260630-workflow-20261105-v2; CMS publication: 2026-06-30; records imported: 2026-11-05T09:06:52.159882+00:00. Page 2 of 6; records 51–100 of 271 matching records. This page contains 50 records (maximum 50), not the full filtered export. [Filtered data set page]. https://industrypayments.org/provider/npi-1477558674?year=2024&recipient=provider&page=2#records-h. Source: https://openpaymentsdata.cms.gov/dataset/e6b17c6a-2534-4207-a4a1-6746a14911ff.
Bluebook
SHANKER N DIXIT, NPI 1477558674, CMS profile ID 157757, IndustryPayments, General Payments, PY2024; Recipient scope: Physicians and non-physician practitioners; Reporting company: All reporting companies; Nature of payment: All payment types (Data edition: cms-20260630-workflow-20261105-v2; CMS publication: 2026-06-30; records imported: 2026-11-05T09:06:52.159882+00:00). Page 2 of 6; records 51–100 of 271 matching records. This page contains 50 records (maximum 50), not the full filtered export. Source: https://openpaymentsdata.cms.gov/dataset/e6b17c6a-2534-4207-a4a1-6746a14911ff. https://industrypayments.org/provider/npi-1477558674?year=2024&recipient=provider&page=2#records-h.

Centers for Medicare & Medicaid Services, Open Payments

Citation formats are provided for reference; check the requirements of your publication.

Payment records · PY2024

Ordering applied by this site (date, newest first, then paying entity) · record values are shown as CMS published them

General Payments · PY2024 · Physicians and non-physician practitioners · CMS publication 2026-06-30

271 matching records · $11,588.02 reported total · 0 disputed

Nature of payment: All payment types

Records imported here (UTC).

Link to these filtered records · CMS source dataset ↗

Download all 271 matching records (CSV)

CSV includes CMS record IDs, source and publication dates, the data edition, and a link to these filters. Formula-like text cells are prefixed with an apostrophe for spreadsheet safety.

Showing records 51–100 of 271.

Paying entityAmountDate Nature of paymentDispute statusPublication flagsPublished Record IDSource
ARGENX US, INC. $10.9210/18/2024 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1142122322 CMS
ABBVIE INC. $10.8610/17/2024 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1103646184 CMS
ABBVIE INC. $12.4410/16/2024 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1103646182 CMS
Takeda Pharmaceuticals U.S.A., Inc. $21.9010/15/2024 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1137532302 CMS
ABBVIE INC. $16.7410/11/2024 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1103646180 CMS
Amneal Pharmaceuticals LLC $21.9010/11/2024 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1139184190 CMS
UCB, Inc. $19.1410/10/2024 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1143211133 CMS
Eisai Inc. $0.6410/09/2024 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1110780952 CMS
Eisai Inc. $32.3910/08/2024 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1110780950 CMS
Neurelis, Inc. $0.5410/08/2024 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1145640272 CMS
Neurelis, Inc. $27.4110/08/2024 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1145640274 CMS
Neurocrine Biosciences, Inc. $38.0410/05/2024 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1150816218 CMS
Neurocrine Biosciences, Inc. $3.2710/04/2024 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1150889652 CMS
Lundbeck LLC $19.0310/03/2024 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1145911093 CMS
Lundbeck LLC $14.5810/03/2024 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1145911095 CMS
Merz Pharmaceuticals, LLC $18.3010/02/2024 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1137954756 CMS
Ipsen Biopharmaceuticals, Inc $33.4510/01/2024 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1091969531 CMS
Novartis Pharmaceuticals Corporation $13.4009/27/2024 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1086917321 CMS
EMD Serono, Inc. $24.5109/25/2024 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1120261316 CMS
Medtronic, Inc. $145.4909/25/2024 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1119335959 CMS
Genentech USA, Inc. $31.7009/24/2024 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1133111135 CMS
ABBVIE INC. $8.4709/20/2024 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1103646178 CMS
Eisai Inc. $23.7109/20/2024 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1110780928 CMS
Lundbeck LLC $1.0509/20/2024 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1145911091 CMS
Eisai Inc. $0.5909/19/2024 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1110780926 CMS
Lundbeck LLC $23.2809/18/2024 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1145911089 CMS
UCB, Inc. $100.6609/18/2024 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1143211128 CMS
PFIZER INC. $27.0909/17/2024 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1131997901 CMS
ABBVIE INC. $12.4409/14/2024 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1103646176 CMS
Teva Pharmaceuticals USA, Inc. $1.6009/11/2024 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1151545119 CMS
Teva Pharmaceuticals USA, Inc. $39.7309/11/2024 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1151545121 CMS
UCB, Inc. $19.6209/10/2024 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1143211123 CMS
ABBVIE INC. $29.6009/04/2024 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1103646174 CMS
Biogen, Inc. $27.0209/04/2024 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1104812143 CMS
Biogen, Inc. $1.5509/04/2024 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1104825162 CMS
ABBVIE INC. $10.8909/03/2024 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1103646172 CMS
ARGENX US, INC. $23.5308/31/2024 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1142122390 CMS
Takeda Pharmaceuticals U.S.A., Inc. $28.6808/29/2024 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1137532298 CMS
Neurelis, Inc. $22.9708/28/2024 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1145640270 CMS
Novartis Pharmaceuticals Corporation $0.7208/27/2024 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1086917311 CMS
Novartis Pharmaceuticals Corporation $22.6608/27/2024 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1086917313 CMS
AstraZeneca Pharmaceuticals LP $16.8608/23/2024 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1104343912 CMS
Lundbeck LLC $19.8708/22/2024 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1145911087 CMS
Biogen, Inc. $1.2008/21/2024 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1104825160 CMS
Biogen, Inc. $22.2708/20/2024 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1104815459 CMS
Ipsen Biopharmaceuticals, Inc $34.6308/16/2024 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1091969529 CMS
Neurocrine Biosciences, Inc. $16.2908/16/2024 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1150871353 CMS
ABBVIE INC. $13.0908/14/2024 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1103646170 CMS
Lundbeck LLC $24.4908/14/2024 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1145911085 CMS
MDD US Operations, LLC $19.3108/14/2024 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1147750428 CMS

By program year

All program years on this page · sorted by year

Program yearAmountRecords
PY2019 $9,663.07 207
PY2020 $15,113.52 194
PY2021 $55,249.25 293
PY2022 $17,787.36 264
PY2023 $16,948.42 273
PY2024 $11,588.02 271
PY2025 $10,275.77 204

Source & provenance

Dataset
CMS Open Payments — General Payments
Publisher of source data
Centers for Medicare & Medicaid Services
CMS publication date
2026-06-30
Program years on this page
2019, 2020, 2021, 2022, 2023, 2024, 2025
Source files and profile matching
Generated from
OP_DTL_GNRL_PGYR2025_P06302026_06032026.csv

One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.

Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.

Research Payments

One row per program year and role, newest year first · amounts for the two roles are never added together

Program yearRoleAmountRecords
PY2025 Principal investigator $36,714.74 8
PY2024 Principal investigator $123,240.70 4
PY2023 Recipient $410.00 1
PY2023 Principal investigator $169,276.40 5
PY2022 Recipient $591.00 1
PY2022 Principal investigator $173,808.55 18
PY2021 Recipient $2,401.37 1
PY2021 Principal investigator $211,291.45 22
PY2020 Recipient $5,000.00 1
PY2020 Principal investigator $61,505.32 36
PY2019 Recipient $11,261.00 5
PY2019 Principal investigator $318,668.61 37

Research Payments are a separate CMS dataset, shown here separately and never added to General Payments. A research payment is often made to an institution, with this provider named as a principal investigator; each record states which role applies.

“If you are a physician who served as a principal investigator on a research study, you may see the payments associated with that research study listed under your name. This does not necessarily mean the payments are attributed to you. The dollar amount of the record corresponds to the total payment; the amounts are not attributed to each individual on the record.”

— Centers for Medicare & Medicaid Services, Open Payments Frequently Asked Questions, FAQ #12224

Research Payments records · PY2025

Ordering applied by this site (date, newest first, then paying entity) · record values are shown as CMS published them

8 records in PY2025

Research Payments records (CSV)

RolePaying entityAmount DateRecipientStudy Dispute statusPublishedRecord ID
Principal investigator 1 Ipsen Innovation $2,500.00 05/26/2025 Non-covered Recipient Entity
Las Vegas Medical Research Center
Phase III, Randomised, Double-blind, Placebo-controlled, Multicenter, Parallel-group Study with Extension Phase to Evaluate the Efficacy and Safety of Dysport for the Prevention of Chronic Migraine in Adult Participants No dispute reported 06/30/2026 1184302017
Principal investigator 1 Ipsen Innovation $615.00 05/26/2025 Non-covered Recipient Entity
Las Vegas Medical Research Center
Phase III, Randomised, Double-blind, Placebo-controlled, Multicenter, Parallel-group Study with Extension Phase to Evaluate the Efficacy and Safety of Dysport for the Prevention of Chronic Migraine in Adult Participants No dispute reported 06/30/2026 1184302019
Principal investigator 1 Ipsen Innovation $1,000.00 05/26/2025 Non-covered Recipient Entity
Las Vegas Medical Research Center
Phase III, Randomised, Double-blind, Placebo-controlled, Multicenter, Parallel-group Study with Extension Phase to Evaluate the Efficacy and Safety of Dysport for the Prevention of Chronic Migraine in Adult Participants No dispute reported 06/30/2026 1184302021
Principal investigator 1 Ipsen Innovation $1,500.00 05/26/2025 Non-covered Recipient Entity
Las Vegas Medical Research Center
Phase III, Randomised, Double-blind, Placebo-controlled, Multicenter, Parallel-group Study with Extension Phase to Evaluate the Efficacy and Safety of Dysport for the Prevention of Chronic Migraine in Adult Participants No dispute reported 06/30/2026 1184302023
Principal investigator 1 Ipsen Innovation $6,000.00 05/26/2025 Non-covered Recipient Entity
Las Vegas Medical Research Center
Phase III, Randomised, Double-blind, Placebo-controlled, Multicenter, Parallel-group Study with Extension Phase to Evaluate the Efficacy and Safety of Dysport for the Prevention of Chronic Migraine in Adult Participants No dispute reported 06/30/2026 1184302025
Principal investigator 1 Ipsen Innovation $1,500.00 05/26/2025 Non-covered Recipient Entity
Las Vegas Medical Research Center
Phase III, Randomised, Double-blind, Placebo-controlled, Multicenter, Parallel-group Study with Extension Phase to Evaluate the Efficacy and Safety of Dysport for the Prevention of Chronic Migraine in Adult Participants No dispute reported 06/30/2026 1184302027
Principal investigator 1 Eli Lilly and Company $911.74 02/25/2025 Non-covered Recipient Entity
INTERSPOND LLC
ASSESSMENT OF SAFETY, TOLERABILITY, AND EFFICACY OF DONANEMAB IN EARLY SYMPTOMATIC ALZHEIMERS DISEASE No dispute reported 06/30/2026 1187884026
Principal investigator 1 Eli Lilly and Company $22,688.00 02/18/2025 Non-covered Recipient Entity
INTERSPOND LLC
ASSESSMENT OF SAFETY, TOLERABILITY, AND EFFICACY OF DONANEMAB IN EARLY SYMPTOMATIC ALZHEIMERS DISEASE No dispute reported 06/30/2026 1187883870